Patient, X .

HRN: 22-19-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2022
CEFTRIAXONE 1G (VIAL)
11/13/2022
11/20/2022
IV
2g
Od
Open Fracture Temporozygomatic Area
Waiting Final Action 
11/13/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/13/2022
11/20/2022
IV
1.5
Q6
Avulsed Wound Frontal Area
Waiting Final Action 
11/14/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/14/2022
11/20/2022
IV
500mg
Q8
Intraabdominal Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: